It mimics the hormone GLP-1, reducing appetite, prolonging fullness, and potentially increasing energy expenditure
Xi C, Liu N, Liang F, Zhao X, Long J, Yuan F, et al
M62.81 fits when the acute infection is no longer the driver, and the record documents: persistent strength reduction functional impairment structured rehab or evaluation plan 4) Idiopathic generalized weakness under active evaluation Use M62.81 when the record supports a real impairment and evaluation is ongoing
Supplements linked to stress support, sleep quality, and energy balance often become part of the conversation too, which is why interest in Ashwagandha with Wegovy continues growing amongst UK patients exploring long-term weight management support